Fidelity Investments’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Fidelity Investments’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-725,715	Closed	-$15.2M	–	2784
2016 Q3	$15.2M	Sell	725,715 -3,453,758	-83%	-$39.8M	﹤0.01%	1814
2016 Q2	$45.1M	Buy	4,179,473 +1,653,200	+65%	+$14.1M	0.01%	1323
2016 Q1	$16.7M	Sell	2,526,273 -748,200	-23%	-$6.8M	﹤0.01%	1752
2015 Q4	$59.3M	Hold	3,274,473	–	–	0.01%	1197
2015 Q3	$36.1M	Hold	3,274,473	–	–	0.01%	1390
2015 Q2	$47.2M	Buy	3,274,473 +394,891	+14%	+$5.36M	0.01%	1359
2015 Q1	$33.7M	Buy	2,879,582 +1,177,300	+69%	+$15.9M	﹤0.01%	1513
2014 Q4	$28.3M	Buy	1,702,282 +1,089,782	+178%	+$15.9M	﹤0.01%	1588
2014 Q3	$4.67M	Buy	+612,500	New	+$4.76M	﹤0.01%	2250

Fidelity Investments's VTAE Position: Q4 2016 in Review

Fidelity Investments sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 725,715 shares — an estimated $15.2M sold.

Fidelity Investments first reported a position in VTAE in Q3 2014 and held it in 9 quarters. The position peaked at $59.3M in Q4 2015. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Fidelity Investments reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Fidelity Investments sold 725,715 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $15.2M.
Fidelity Investments first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2014 and held it in 9 quarters.
Fidelity Investments's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $59.3M in Q4 2015.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Fidelity Investments's 13F filing for Q4 2016, filed 10 Feb 2017.